Immune Sequencing Project Will Test Technology's Ability to Diagnose Pathogen Exposure

The three-year, proof-of-principle project is funded through a $1 million grant from the Keck Foundation. If successful, it could be a step toward the use of sequencing as a replacement for current titering methods to diagnose infection.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.